ALPS today
$1.21+$0.03 (+2.98%)close Nov 13, 2026Trend
DailyUptrend (confirmed)
4 hourExpanding
1 hourBullish
15 minSymmetric Triangle
5 minStrong Bearish
Daily trend turns down below $0.23
Key levels
Resistance$1.72
Resistance$1.39
Support$1.11
Support$0.92
Latest news & SEC filings
ProductAlps Group Inc. Opens Lab Unit for Drug Interaction Testing
ProductAlps Group opens pharmaco-interaction lab in MyGenome unit
NewsAlps Group Inc. shareholders approve share consolidation and capital changes
All ALPS news →About Alps
Alps is a biotechnology firm whose drug candidates are still in laboratory and animal testing, before any human studies. Its programs cover cell-based treatments and tests that use a patient's own tumor cells to guide cancer care. The company works through units in Malaysia and the United States and depends on outside manufacturers.
Based on the company's 20-F filed Aug 6, 2026.
Nasdaq · Healthcare
Alps Group Inc (ALPS)
What Is the Price Target for ALPS?
SEPT Low Target
$0.00
SEPT Mid Target
$0.00
SEPT High Target
$0.00
Analyst Consensus
$0.00
Is ALPS a Buy or Sell Right Now?
Thesis
- •Revenue growing 40.2% YoY with ACCELERATING trend — accelerating momentum.
- •SEC filings signal active product innovation — 1 new product/expansion keywords detected in 10-K. R&D investment stable.
AI-Powered Trading Signals
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for ALPS.
Start Free Trial →Is ALPS Overvalued or Undervalued?
Valuation Verdict
N/A
Methods Used
N/A
Fair Value
$N/A
41
Moat Score
NARROW
4/9
Piotroski Score
-3.8
Altman Z-Score
What Is Smart Money Doing with ALPS?
Insider Signal
NEUTRAL
0 buys / 0 sells (90d)
Congress Signal
NEUTRAL
0 buys / 0 sells (90d)
Institutional
N/A
Short Squeeze Risk
MEDIUM
Signal: NEUTRAL
Track Smart Money Across 4,000+ Stocks
Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.
See All Smart Money Signals →ALPS Growth Story
Revenue YoY
40.3%
3yr Revenue CAGR
N/A%
EPS Growth YoY
-78.95%
FCF Growth YoY
-6.6%
Revenue Trend
ACCELERATING
Dark Pool Trades for ALPS
PREVIEWSEPT Investing tracks real-time dark pool institutional trades for ALPS, including block trade sizes, dollar values, and buy/sell side classification. Dark pool trades reveal where institutional investors are positioning before moves become visible on public exchanges.
| Time | Price | Size | Value | Side |
|---|---|---|---|---|
| 20:58:04 | $1.18 | 1,000 | $$1K | BUY |
| 20:58:04 | $1.18 | 1,000 | $$1K | BUY |
| 20:56:46 | $1.11 | 1,000 | $$1K | MIDPOINT |
| 20:56:03 | $1.13 | 1,000 | $$1K | BUY |
| 20:55:25 | $1.11 | 3,900 | $$4K | SELL |
5 dark pool trades shown · $$9K preview volume
Real-time institutional flow, block trades, and net positioning
Full AI Research Report
SEPT's Trading AI has generated a free, downloadable PDF research report for Alps Group Inc (ALPS) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.
Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (2 articles analyzed), and SEC filing intelligence...
AI-Powered Trading Signals.
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.
Try SEPT Free for 7 Days →ALPS — frequently asked questions
What is ALPS stock price today?
Alps Group Inc (ALPS) is at $1.21, up 2.98% (+$0.03) at the Nov 13, 2026 close.
Why is ALPS stock moving today?
Latest ALPS news — Nov 12, 2026: Alps Group Inc. Opens Lab Unit for Drug Interaction Testing · Nov 12, 2026: Alps Group opens pharmaco-interaction lab in MyGenome unit
Did ALPS beat earnings?
ALPS last reported on Sep 29, 2026: EPS -$0.24.
Does ALPS pay a dividend?
ALPS does not currently pay a dividend.
How much debt does ALPS have?
Alps Group Inc reported $1M of debt and $0M of cash (Mar 31, 2025).
What are ALPS support and resistance levels?
Support: $1.11, $0.92, $0.77. Resistance: $1.39, $1.72, $1.96.
What are insiders doing with ALPS?
Insider activity: NEUTRAL, 0 buys and 0 sells in the last 90 days.
What is the latest news on ALPS?
Nov 12, 2026: Alps Group Inc. Opens Lab Unit for Drug Interaction Testing · Nov 12, 2026: Alps Group opens pharmaco-interaction lab in MyGenome unit · Oct 30, 2026: Alps Group Inc. shareholders approve share consolidation and capital changes